You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally Advanced HPV negative HNSCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Chicago (Carboplatin,

Recruiting
  • Human Papilloma Virus
  • +4 more
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 3, 2022

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Brescia, Italy
      Asst Degli Spedali Civili Di Brescia
    Aug 3, 2022

    Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

    Recruiting
    • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
    Feb 9, 2023

    Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

    Not yet recruiting
    • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
    • Monalizumab
    • Cetuximab
    • (no location specified)
    Jan 8, 2023

    Epigenetic Silencing of MicroRNA for Predicting Therapeutic

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Not interventional
    • Albuquerque, New Mexico
      University of New Mexico - Cancer Center
    Oct 4, 2022

    Head Neck Cancer, Head Neck Cancer Trial in Saint Louis (Pyrimethamine)

    Not yet recruiting
    • Head and Neck Cancer
    • Cancer of the Head and Neck
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 4, 2023

    HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

    Not yet recruiting
    • HPV-Negative Squamous Cell Carcinoma
    • Chicago, Illinois
      University of Chicago Medicine Comprehensive Cancer Center
    Aug 16, 2023

    Squamous Cell Carcinoma of the Head and Neck Trial in Le Havre (Pembrolizumab, Cetuximab, Radiotherapy)

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Le Havre, France
      Centre Guillaume le conquérant
    Aug 18, 2022

    Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

    Recruiting
    • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +5 more
    • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Plasma MRD and cfDNA HPV and Efficacy and Prognosis of Locally

    Recruiting
    • Locally Advanced Cervical Cancer
    • Concurrent chemoradiotherapy
    • Guiyang, Guizhou, China
      Yong Li
    Jul 14, 2023

    Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • 3cycles (Toripalimab + cetuximab)
    • +2 more
    • Wuhan, Hebei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 6, 2023

    Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Sao Paulo (cisplatin, gemcitabine, Follow-up)

    Not yet recruiting
    • Cervical Cancer
    • +2 more
    • cisplatin, gemcitabine
    • Follow-up
    • Sao Paulo, Brazil
      Hospital do Coração - Research Institute
    Mar 1, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Pembrolizumab
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 25, 2022

    Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +7 more
    • La Jolla, California
      UC San Diego Moores Cancer Center
    Jul 20, 2022

    HNSCC Trial in Tucson (Abemaciclib)

    Recruiting
    • HNSCC
    • Tucson, Arizona
      University of Arizona
    Mar 3, 2022

    HNSCC, Radiotherapy, PD-1 Trial in Guangzhou (PD-1inhibitor, concurrent chemoradiotherapy)

    Recruiting
    • HNSCC
    • +2 more
    • Guangzhou, Guangdong, China
      Sun yat-sen memorial hospital
    Aug 6, 2023

    Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Locally Advanced or Recurrent Metastatic HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Sep 12, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Oct 25, 2023

    Adult Solid Tumor Trial in Scottsdale, Aurora, Nashville (SQZ-eAPC-HPV, Pembrolizumab)

    Recruiting
    • Adult Solid Tumor
    • SQZ-eAPC-HPV
    • Pembrolizumab
    • Scottsdale, Arizona
    • +4 more
    Jan 26, 2023

    Using Peripheral Blood Circulating Tumor DNA in Cervical Cancer

    Recruiting
    • Locally Advanced Cervical Cancer
    • detect HPV and genetic variants
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 28, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • dose-reduced radiotherapy
    • Zhuhai, Guangdong, China
      Fifth Affiliated Hospital of Sun Yat-sen University
    May 3, 2023